Enfusion, Inc. (NYSE:ENFN – Get Free Report) shares were up 4.3% during mid-day trading on Monday . The company traded as high as $9.38 and last traded at $9.37. Approximately 229,194 shares changed hands during trading, a decline of 40% from the average daily volume of 380,004 shares. The stock had previously closed at $8.98.
Enfusion Stock Performance
The stock’s 50 day moving average price is $8.53 and its 200-day moving average price is $8.88. The company has a market cap of $1.22 billion, a PE ratio of 299.33, a PEG ratio of 2.23 and a beta of 0.90.
Enfusion (NYSE:ENFN – Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.01). The company had revenue of $49.46 million during the quarter, compared to analysts’ expectations of $50.27 million. Enfusion had a return on equity of 6.17% and a net margin of 1.98%. On average, analysts anticipate that Enfusion, Inc. will post 0.07 EPS for the current year.
Institutional Investors Weigh In On Enfusion
Enfusion Company Profile
Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.
Featured Articles
- Five stocks we like better than Enfusion
- What Are Trending Stocks? Trending Stocks Explained
- The Average 401k Balance by Age Explained
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Enfusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enfusion and related companies with MarketBeat.com's FREE daily email newsletter.